Search details
1.
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.
Proc Natl Acad Sci U S A
; 118(8)2021 02 23.
Article
in English
| MEDLINE | ID: mdl-33602823
2.
Systems-based digital twins to help characterize clinical dose-response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL.
Clin Transl Sci
; 16(7): 1134-1148, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36908269
3.
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199.
Mol Cancer Ther
; 20(12): 2483-2494, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34711645
4.
Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia.
Cancer Immunol Res
; 8(6): 806-818, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32238381
5.
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients.
Nat Med
; 25(6): 929-935, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31171876
6.
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.
Nat Commun
; 7: 12624, 2016 08 30.
Article
in English
| MEDLINE | ID: mdl-27571927
Results
1 -
6
de 6
1
Next >
>>